British study to test mixed COVID-19 vaccine dose schedules in children

A British study will look into the immune responses of children to mixed schedules of different COVID-19 vaccines as officials try to determine the best approach to second doses in adolescents given a small risk of heart inflammation.Children aged 12-15 in Britain will be vaccinated from next week

Moderna says Covid-19 vaccine protection wanes, makes case for booster

New data from Moderna Inc’s large Covid-19 vaccine trial shows that the protection it offers wanes over time, supporting the case for booster doses, the company said in a news release on Wednesday. “This is only one estimate, but we do believe this means as you look toward the fall an

COVID-19 vaccine booster not necessary, Lancet study says

Athird booster shot for the general population is not required as COVID-19 vaccines are effective enough at preventing severe illness, according to a report published by The Lancet on Monday. Some countries have started offering extra doses over fears about the much more contagious delta variant,

COVID-19 vaccine developed by Turkey to be tested in Kyrgyzstan

Kyrgyzstan has agreed to conduct Phase 3 trials of Turkovac, Turkey’s first locally-made vaccine to reach that stage. Turkish Vice President Fuat Oktay, who visited the Central Asian country last week, told Anadolu Agency (AA) Sunday that they reached a deal with Kyrgyz President Sadyr Japar

Trial COVID-19 Vaccines Grown in Cowpea Mosaic Virus

Nanoengineers at the University of California San Diego have developed COVID-19 vaccine candidates that can take the heat. Their key ingredients are viruses and bacteria that affect plants. The new fridge-free COVID-19 vaccines are still in the early stage of development. In experiments conducted

Vitamin D and lumisterol emerge as cheap and easily accessible potential treatments for COVID-19

Promising new data from a recent study indicates that active forms of vitamin D can inhibit the replication and expansion of COVID-19. The study's findings also suggest lumisterol, produced by a chemical reaction in the body using light, works to block COVID-19. Vitamin D and lumisterol metabolite

Nerve Disorder Listed as 'Very Rare' Side Effect of AstraZeneca Jab

The European Medicines Agency has listed the neurological disorder Guillain-Barre syndrome, which can cause temporary paralysis, as a "very rare" side effect of the AstraZeneca Covid-19 vaccine. A causal relationship was "considered at least a reasonable possibility", the EMA said in an update We

Baricitinib does not cut COVID-19 progression in hospitalized adults

For hospitalized adults with COVID-19, treatment with baricitinib in addition to standard of care does not reduce the frequency of disease progression overall, but it is associated with reduced mortality, according to a study published online Sept. 1 in The Lancet Respiratory Medicine.  

EU watchdog evaluating data on COVID-19 vaccine booster shot

The European Union's drug regulator said Monday it was evaluating data on a booster dose for the COVID-19 vaccine made by Pfizer-BioNTech. In a statement Monday, the European Medicines Agency (EMA) said it is considering whether a third dose of the vaccine should be given six months aft

$26 billion opioid settlement ready for next step: US drug firms

Four pharmaceutical companies have said they received enough support from US states to move to the next stage of a $26 billion settlement over thousands of legal claims related to the opioid epidemic.   The opioid crisis—exacerbated by the coronavirus pandemic—has killed more th

NIH launches study of extra COVID-19 vaccine dose in people with autoimmune disease

The National Institutes of Health has begun a clinical trial to assess the antibody response to an extra dose of an authorized or approved COVID-19 vaccine in people with autoimmune disease who did not respond to an original COVID-19 vaccine regimen. The trial also will investigate whether pausing

J&J's HIV vaccine fails Africa trial in latest blow to field

Amuch anticipated HIV vaccine developed by Johnson & Johnson failed to provide sufficient protection in a clinical trial, the company and United States health authorities announced Tuesday. The trial involved more than 2,600 young women in sub-Saharan Africa. Though the vaccine was found to

Uzbek scientists test edible COVID-19 vaccine

Researchers in Uzbekistan are testing an "edible transgenic tomato vaccine" as part of the efforts to contain the ongoing COVID-19 pandemic. Scientists from the Center for Genomics and Bioinformatics of the Academy of Sciences are working to develop an edible vaccine against the virus by changing

Pfizer-BioNTech COVID-19 vaccine gains full US regulatory approval

The US drug regulator on Monday granted full approval to the Pfizer Inc/BioNTech COVID-19 vaccine — the first to secure such Food and Drug Administration validation — prompting President Joe Biden to make a fresh pitch to vaccine skeptics to get the shot to fight the relentless pandemi

Extra COVID vaccine OK’d for those with weak immune systems

U.S. regulators say transplant recipients and others with severely weakened immune systems can get an extra dose of the Pfizer or Moderna COVID-19 vaccines to better protect them as the delta variant continues to surge. The late-night announcement Thursday by the Food and Drug Administration appl

Israeli Survey Finds 3rd Pfizer Vaccine Dose Has Similar Side Effects to 2nd

Most people who received a third dose of Pfizer Inc’s COVID-19 vaccine felt similar or fewer side effects than they did after receiving the second shot, according to an initial survey in Israel. Israel began offering the booster shots about 10 days ago to people over age 60 as part of effor

One dose of Pfizer vaccine may be enough for folks who've had COVID: study

I think I've had COVID-19 already, so do I really need two doses of vaccine?   It's a question millions of people around the world are asking, and now a small, new study finds that people who know they were infected with SARS-CoV-2 in the past may need only one shot of the Pfizer vaccine to

Scientists are studying the effectiveness of the Russian "EpiVacCorona" vaccine

It became clear to scientists about the effectiveness of the Russian “EpiVacCorona” vaccine, that IgG antibodies arose in 79 percent of the volunteers 42 days after they were vaccinated. The newspaper "Izvestia" indicates that 2,999 volunteers participated in the "EpiVacCorona" vaccin